Financiën Chongqing Zhifei Biological Products Co., Ltd.
Aandelen
300122
CNE100000V20
Farmaceutische producten
|
Slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 19,37 CNY | -0,05% |
|
-2,96% | -26,35% |
Voorlopige winst- en verliesrekening: Chongqing Zhifei Biological Products Co., Ltd.
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 15.190 | 30.637 | 38.264 | 52.918 | 26.070 | 10.623 | 16.354 | 13.963 |
| Variatie | - | 101,68% | 24,9% | 38,3% | -50,74% | -59,25% | 53,95% | -14,62% |
| EBITDA 1 | 4.027 | 12.394 | 9.079 | 9.700 | 2.656 | -1.590 | 707,4 | 2.138 |
| Variatie | - | 207,81% | -26,75% | 6,84% | -72,62% | -159,87% | 144,48% | 202,28% |
| Bedrijfsresultaat (EBIT) 1 | 3.894 | 11.986 | 8.758 | 9.373 | 2.264 | -1.560 | 132,9 | 1.532 |
| Variatie | - | 207,82% | -26,93% | 7,02% | -75,85% | -168,91% | 108,52% | 1.053,17% |
| Betaalde rente 1 | -131,4 | -21,82 | -13,8 | -47,22 | -109,3 | -156 | -72 | -8 |
| Resultaat voor belastingen (EBT) 1 | 3.853 | 11.917 | 8.718 | 9.342 | 2.254 | -2.182 | 867,3 | 1.466 |
| Variatie | - | 209,3% | -26,85% | 7,16% | -75,88% | -196,82% | 139,75% | 68,98% |
| Nettowinst (verlies) 1 | 3.300 | 10.197 | 7.539 | 8.070 | 2.018 | -1.811 | 762,1 | 1.307 |
| Variatie | - | 208,96% | -26,07% | 7,04% | -74,99% | -189,71% | 142,09% | 71,52% |
| Datum van publicatie | 21-02-21 | 08-02-22 | 20-03-23 | 22-04-24 | 21-04-25 | - | - | - |
1CNY in Miljoen
Geschatte gegevens
Balansprognose: Chongqing Zhifei Biological Products Co., Ltd.
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuld 1 | 1.437 | -3.502 | -617 | -3.330 | 9.643 | -4.564 | -8.938 | -9.965 |
| Variatie | - | -343,7% | 82,38% | -439,71% | 389,58% | -147,33% | -95,84% | -11,49% |
| Datum van publicatie | 21-02-21 | 08-02-22 | 20-03-23 | 22-04-24 | 21-04-25 | - | - | - |
1CNY in Miljoen
Geschatte gegevens
Verwachte kasstroom: Chongqing Zhifei Biological Products Co., Ltd.
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 826,9 | 1.932 | 1.452 | 966,1 | 925,6 | 270 | 319,3 | 291,5 |
| Variatie | - | 133,62% | -24,81% | -33,49% | -4,19% | -70,83% | 18,26% | -8,7% |
| Vrije kasstroom (FCF) 1 | 2.670 | 6.576 | 536,6 | 8.030 | -5.340 | 12.315 | 5.364 | - |
| Variatie | - | 146,3% | -91,84% | 1.396,57% | -166,49% | 330,64% | -56,45% | -100% |
| Datum van publicatie | 21-02-21 | 08-02-22 | 20-03-23 | 22-04-24 | 21-04-25 | - | - | - |
1CNY in Miljoen
Geschatte gegevens
Verwachte financiële ratio's: Chongqing Zhifei Biological Products Co., Ltd.
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
| EBITDA-marge (%) | 26,51% | 40,46% | 23,73% | 18,33% | 10,19% | -14,97% | 4,33% | 15,31% |
| EBIT-marge (%) | 25,63% | 39,12% | 22,89% | 17,71% | 8,68% | -14,69% | 0,81% | 10,97% |
| EBT-marge (%) | 25,37% | 38,9% | 22,78% | 17,65% | 8,64% | -20,54% | 5,3% | 10,5% |
| Nettomarge (%) | 21,73% | 33,28% | 19,7% | 15,25% | 7,74% | -17,05% | 4,66% | 9,36% |
| FCF-marge (%) | 17,58% | 21,46% | 1,4% | 15,18% | -20,48% | 115,93% | 32,8% | - |
| Vrije kasstroom/nettoresultaat (%) | 80,89% | 64,49% | 7,12% | 99,51% | -264,53% | -680,11% | 703,78% | - |
Winstgevendheid | ||||||||
| ROA | 25,23% | 45,08% | - | 18,29% | 4,03% | 6,81% | 5,47% | 4,5% |
| ROE | 46,28% | 77,96% | 36,13% | 29,09% | 6,46% | -5,95% | 5,21% | 4,89% |
Financiële gezondheid | ||||||||
| Hefboom (schuld/ebitda) | 0,36x | - | - | - | 3,63x | - | - | - |
| Schuld/vrije kasstroom | 0,54x | - | - | - | -1,81x | - | - | - |
Kapitaalintensiteit | ||||||||
| Kapitaaluitgaven/omzet (%) | 5,44% | 6,31% | 3,8% | 1,83% | 3,55% | 2,54% | 1,95% | 2,09% |
| CAPEX / EBITDA (%) | 20,54% | 15,59% | 16% | 9,96% | 34,85% | -16,98% | 45,14% | 13,63% |
| CAPEX / FCF (%) | 30,97% | 29,38% | 270,69% | 12,03% | -17,33% | 2,19% | 5,95% | - |
Bestanddelen per aandeel | ||||||||
| Kasstroom per aandeel 1 | 1,457 | 3,545 | 0,8287 | 3,748 | -1,844 | 5,304 | 2,409 | - |
| Variatie | - | 143,31% | -76,62% | 352,32% | -149,19% | 387,63% | -54,57% | - |
| Dividend per aandeel 1 | 0,3333 | 0,4 | 0,3333 | 0,8 | 0,2 | - | 0,1104 | 0,035 |
| Variatie | - | 20% | -16,67% | 140% | -75% | - | - | -68,29% |
| Nettoactief per aandeel 1 | 3,433 | 7,357 | 10,1 | 13,13 | 12,88 | 12,07 | 13,58 | 13,2 |
| Variatie | - | 114,29% | 37,26% | 30% | -1,89% | -6,29% | 12,47% | -2,78% |
| WPA 1 | 1,375 | 4,249 | 3,141 | 3,362 | 0,8427 | -0,7559 | 0,5168 | 0,5471 |
| Variatie | - | 208,95% | -26,07% | 7,04% | -74,94% | -189,7% | 168,37% | 5,85% |
| Aantal aandelen (in duizend) | 2.400.000 | 2.400.000 | 2.400.000 | 2.400.000 | 2.393.790 | 2.393.790 | 2.393.790 | 2.393.790 |
| Datum van publicatie | 21-02-21 | 08-02-22 | 20-03-23 | 22-04-24 | 21-04-25 | - | - | - |
1CNY
Geschatte gegevens
| 2025 * | 2026 * | |
|---|---|---|
| k/w-verhouding | -25,6x | 37,5x |
| PBR-ratio | 1,6x | 1,43x |
| EV/omzet | 3,94x | 2,29x |
| Dividendrendement | - | 0,57% |
Meer waarderingsratio's
* Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Trader
Trader
Beleggings
Beleggings
Globaal
Globaal
Kwaliteit van de publicaties
Kwaliteit van de publicaties
ESG MSCI
AA
Verkoop
Koop
Gemiddeld advies
Kopen
Aantal analisten
7
Laatste slotkoers
19,37CNY
Gemiddelde koersdoel
24,98CNY
Spread / Gemiddelde doel
+28,96%
Kwartaalomzet - Afwijkingspercentage
- Beurs
- Aandelen
- Koers 300122
- Financiën Chongqing Zhifei Biological Products Co., Ltd.
Kies jouw editie
Alle financiële informatie op nationaal niveau
